Les ellipticines et aza-ellipticines = Ellipticins and aza-ellipticinsGISSELBRECHT, C; MARTY, M; MIGNOT, L et al.Actualités hématologiques. 1984, Vol 18, pp 193-207, issn 0567-8757Article

Flexibility of single-subject experimental designs. III: Using flexibility to design or modify experimentsCONNELL, P. J; THOMPSON, C. K.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 214-225, issn 0022-4677Article

Flexibility of single-subject experimental designs. I: Review of the basics of single-subject designsMCREYNODS, L. V; THOMSON, C. K.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 194-203, issn 0022-4677Article

Flexibility of single-subject experimental designs. II: Design selection and arrangement of experimental phasesKEARNS, K. P.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 204-214, issn 0022-4677Article

Clinical evaluation of antitumor therapyMUGGIA, F. M; ROZENCWEIG, M.Developments in oncology. 1986, Vol 46, issn 0167-4927, XII-219 pSerial Issue

The clinical evaluation of anti-rheumatic drugsCATALANO, M. A.Collection sécurité. 1986, Vol 19, Num 3-4, pp 244-245, issn 0538-4818Article

Proceedings/Symposium on the development of a drug, LHRH agonists: 3rd. international congress of andrology, Boston MA, April 27-May 2, 1985VICKERY, B. H.Journal of andrology. 1987, Vol 8, Num 1, pp S.1-S.31, issn 0196-3635Conference Proceedings

Proceedings/Clinical trials in oncology: ethics, errors, methods and results, international symposium, Villejuif, France, 25-29 June 1984MATHE, G; REIZENSTEIN, P; DICATO, M et al.Drugs under experimental and clinical research. 1986, Vol 12, Num 1-3, pp 1-298, issn 0378-6501Conference Proceedings

Essai clinique de l'acide tranexamiqueSUGIMORI, S; UEDA, K.Yakuri to chiryo. 1986, Vol 14, Num 1, pp 431-441, issn 0386-3603Article

Etude clinique de Benobil^® Tim 4TAKESHI, A.Yakuri to chiryo. 1986, Vol 14, Num 1, pp 349-358, issn 0386-3603Article

Reasonable men and sick human beingsSHERLOCK, R.The American journal of medicine. 1986, Vol 80, Num 1, pp 2-4, issn 0002-9343Article

Abstracts. II/III world conference on clinical pharmacology & therapeutics, Stockholm, July 27-August 1, 1986Acta pharmacologica et toxicologica. Supplement. 1986, Vol 59, Num 5, issn 0065-1508, 224 p.Conference Proceedings

On the mathematical basis of Zelen's prerandomized designsBRUNNER, E; NEUMANN, N.Methods of information in medicine. 1985, Vol 24, Num 3, pp 120-130, issn 0026-1270Article

The randomized clinical trial in orthopaedics: obligation or option?RUDICEL, S; ESDAILE, J.Journal of bone and joint surgery. American volume. 1985, Vol 67, Num 8, pp 1284-1293, issn 0021-9355Article

Closing the loop: providing feedback on drug developmentMUGGIA, F. M.Cancer treatment reports. 1987, Vol 71, Num 1, pp 1-2, issn 0361-5960Article

Interventions/Séminaire «Bonnes pratiques cliniques», Paris, 20 novembre 1986 = Interventions/Seminar «clinical good practices», Paris, 20 November 1986La Revue de médecine interne (Paris). 1986, pp 7-20, issn 0248-8663, no specConference Proceedings

Evaluation of test data from clinical studies. I: Terminology, graphic interpretation, diagnostic strategies, and selection of sample groups. II: Critical review of the concepts of efficiency, receiver operated characteristics (ROC), and likelihood ratiosGERHARDT, W; KELLER, H.Scandinavian journal of clinical & laboratory investigation. Supplement. 1986, Vol 86, Num 181, issn 0085-591X, 74 p.Serial Issue

Current concepts review: methodological guidelines for clinical trials evaluating new therapeutic approaches in bone and joint surgeryRASKOB, G. E; LOFTHOUSE, R. N; HULL, R. D et al.Journal of bone and joint surgery. American volume. 1985, Vol 67, Num 8, pp 1294-1297, issn 0021-9355Article

Design Issues in Randomized Phase II/III TrialsKORN, Edward L; FREIDLIN, Boris; ABRAMS, Jeffrey S et al.Journal of clinical oncology. 2012, Vol 30, Num 6, pp 667-671, issn 0732-183X, 5 p.Article

Characterization and multiparameter analysis of visual adverse events in Irofulven single-agent Phase I and II trialsRAYMOND, Eric; KAHATT, Carmen; CULLEN, Michael et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7566-7574, issn 1078-0432, 9 p.Article

Journées de pharmacogie cliniqueThérapie (Paris). 1992, Vol 47, Num 5, pp 455-465, issn 0040-5957Conference Proceedings

Presidential address: fractionation: a paradigm for clinical research in radiation oncologyCOX, J. D.International journal of radiation oncology, biology, physics. 1987, Vol 13, Num 9, pp 1271-1281, issn 0360-3016Article

Randomized phase II clinical trialsSIMON, R; WITTES, R. E; ELLENBERG, S. S et al.Cancer treatment reports. 1985, Vol 69, Num 12, pp 1375-1381, issn 0361-5960Article

Unresolved issues in combination chemotherapyWITTES, R. E; GOLDIN, A.Cancer treatment reports. 1986, Vol 70, Num 1, pp 105-125, issn 0361-5960Article

Methodologic guidelines for reports of clinical trialsAmerican journal of clinical oncology. 1986, Vol 9, Num 3, pp 276-277, issn 0277-3732Article